Center for Scientific Review; Notice of Closed Meetings, 66462-66463 [2023-20980]
Download as PDF
<![CDATA[
66462
Federal Register / Vol. 88, No. 186 / Wednesday, September 27, 2023 / Notices
Type of Collection: Reinstatement
without change.
OMB No.: 0990–0324.
Abstract: Pursuant to the Paperwork
Reduction Act of 1995, the
Commissioned Corps Headquarters
(CCHQ), Office of the Secretary,
Department of Health and Human
Services (HHS), requests that the Office
of Management and Budget (OMB)
renew the form PHS–6355 Report of
Dental Examination of Applicants to the
Commissioned Corps of the Public
Health Service for use in determining
the medical qualifications of applicants
to the Commissioned Corps of the U.S.
Public Health Service (Corps).
Applicants to the Corps must meet the
Corps’ medical standards for
appointment.
This is a 3-year request for OMB
approval.
Likely Respondents: U.S. citizens
applying to the United States Public
Health Service.
ANNUALIZED BURDEN HOUR TABLE
Total
burden
hours
PHS–6355 .........................................
Applicants .........................................
1,000
1
1
1,000
Total ...........................................
...........................................................
........................
........................
........................
1,000
[FR Doc. 2023–21098 Filed 9–26–23; 8:45 am]
BILLING CODE 4150–49–P
[FR Doc. 2023–20978 Filed 9–26–23; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Allergy, Immunology,
and Transplantation Research Committee.
Date: October 17–18, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G51A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Thomas F. Conway, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G51A, Bethesda, MD
20892, 240–507–9685, thomas.conway@
nih.gov.
VerDate Sep<11>2014
18:44 Sep 26, 2023
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 21, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ddrumheller on DSK120RN23PROD with NOTICES1
Average
burden per
response
Respondents
(if necessary)
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
Number of
respondents
Number of
responses per
respondents
Forms
(if necessary)
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Social Sciences and Population Studies, A
Study Section.
Date: October 17–18, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Plaza Hotel, 10 Thomas
Circle NW, Washington, DC 20005.
Contact Person: Suzanne Ryan, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00102
Fmt 4703
Sfmt 4703
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 435–
1712, ryansj@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Imaging Guided
Interventions and Surgery Study Section.
Date: October 19–20, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Blvd., Gaithersburg, MD 20878.
Contact Person: Ella Fung Jones, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 496–0777, ella.jones@nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Cellular and Molecular
Biology of Glia Study Section.
Date: October 19–20, 2023.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sung-Wook Jang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 812P,
Bethesda, MD 20892, (301) 435–1042,
jangs2@csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Lung Injury, Repair, and Remodeling
Study Section.
Date: October 19–20, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ghenima Dirami, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7814, Bethesda, MD 20892, 240–498–
7546, diramig@csr.nih.gov.
E:\FR\FM\27SEN1.SGM
27SEN1
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 186 / Wednesday, September 27, 2023 / Notices
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Clinical Integrative Cardiovascular
and Hematological Sciences Study Section.
Date: October 19–20, 2023.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Alexandria Old
Town, 1900 Diagonal Road, Alexandria, VA
22314.
Contact Person: Margaret Chandler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4126,
MSC 7814, Bethesda, MD 20892, (301) 435–
1743, margaret.chandler@nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Biodata Management and Analysis
Study Section.
Date: October 19–20, 2023.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bethesdan Hotel, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: E. Bryan Crenshaw, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–7129, bryan.crenshaw@
nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Clinical
Translational Imaging Science Study Section.
Date: October 19–20, 2023.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: North Bethesda Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road North, Bethesda, MD 20852.
Contact Person: Eleni Apostolos Liapi, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, (301) 867–5309, eleni.liapi@nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Interdisciplinary Clinical Care in Specialty
Care Settings Study Section.
Date: October 19–20, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bethesdan Hotel, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Abu Saleh Mohammad
Abdullah, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 827–4043,
abuabdullah.abdullah@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Sep<11>2014
18:44 Sep 26, 2023
Jkt 259001
Dated: September 21, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–20980 Filed 9–26–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of an Exclusive
Patent License: Development and
Commercialization of Engineered T
Cell Therapies for the Treatment of
Cancer
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Cancer Institute,
an institute of the National Institutes of
Health, Department of Health and
Human Services, is contemplating the
grant of an Exclusive Patent License to
practice the inventions embodied in the
Patents and Patent Applications listed
in the SUPPLEMENTARY INFORMATION
section of this notice to Moonlight Bio,
Inc. (‘‘Moonlight’’), headquartered in
Seattle, WA.
DATES: Only written comments and/or
applications for a license which are
received by the National Cancer
Institute’s Technology Transfer Center
on or before October 12, 2023 will be
considered.
ADDRESSES: Requests for copies of the
patent applications, inquiries, and
comments relating to the contemplated
Exclusive Patent License should be
directed to: Andrew Burke, Ph.D.,
Senior Technology Transfer Manager,
NCI Technology Transfer Center,
Telephone: (240)-276–5484; Email:
andy.burke@nih.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Intellectual Property
1. United States Provisional Patent
Application No. 63/492,256 filed March
27, 2023, entitled ‘‘T Cell Receptors
Targeting Y220C or R175H Mutation in
P53’’ [HHS Reference No. E–054–2023–
0–US–01].
The patent rights in these inventions
have been assigned and/or exclusively
licensed to the government of the
United States of America.
The prospective exclusive license
territory may be worldwide, and the
field of use may be limited to the
following:
‘‘Development, manufacture and
commercialization of autologous T cell
therapy products genetically engineered
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
66463
to express a P53 R175H-reactive TCR
claimed in the Licensed Patent Rights
for the treatment of cancer in humans.’’
The E–054–2023 patent family is
primarily directed to isolated T cell
receptors (TCRs) reactive to certain
mutated forms of tumor protein 53
(TP53 or P53), within the context of
several human leukocyte antigens. P53
is the archetypal tumor suppressor gene
and the most frequently mutated gene in
cancer. Contemporary estimates suggest
that >50% of all tumors carry mutations
in P53. Because of its prevalence in
cancer and its restricted expression to
precancerous and cancerous cells, this
antigen may be targeted on mutant P53expressing tumors with minimal normal
tissue toxicity.
This notice is made in accordance
with 35 U.S.C. 209 and 37 CFR part 404.
The prospective exclusive license will
be royalty bearing, and the prospective
exclusive license may be granted unless
within fifteen (15) days from the date of
this published notice, the National
Cancer Institute receives written
evidence and argument that establishes
that the grant of the license would not
be consistent with the requirements of
35 U.S.C. 209 and 37 CFR part 404.
In response to this notice, the public
may file comments or objections.
Comments and objections, other than
those in the form of a license
application, will not be treated
confidentially and may be made
publicly available.
License applications submitted in
response to this notice will be presumed
to contain business confidential
information and any release of
information from these license
applications will be made only as
required and upon a request under the
Freedom of Information Act, 5 U.S.C.
552.
Dated: September 21, 2023.
Richard U. Rodriguez,
Associate Director, Technology Transfer
Center, National Cancer Institute.
[FR Doc. 2023–21050 Filed 9–26–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
E:\FR\FM\27SEN1.SGM
27SEN1
]]>Agencies
[Federal Register Volume 88, Number 186 (Wednesday, September 27, 2023)]
[Notices]
[Pages 66462-66463]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20980]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Social Sciences and Population Studies, A
Study Section.
Date: October 17-18, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Plaza Hotel, 10 Thomas Circle NW, Washington,
DC 20005.
Contact Person: Suzanne Ryan, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 20892, (301) 435-
1712, [email protected].
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group; Imaging Guided Interventions
and Surgery Study Section.
Date: October 19-20, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Blvd., Gaithersburg, MD 20878.
Contact Person: Ella Fung Jones, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-0777,
[email protected].
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Cellular and Molecular Biology
of Glia Study Section.
Date: October 19-20, 2023.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Sung-Wook Jang, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 812P, Bethesda, MD 20892, (301)
435-1042, [email protected].
Name of Committee: Cardiovascular and Respiratory Sciences
Integrated Review Group; Lung Injury, Repair, and Remodeling Study
Section.
Date: October 19-20, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ghenima Dirami, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122, MSC 7814, Bethesda, MD
20892, 240-498-7546, [email protected].
[[Page 66463]]
Name of Committee: Cardiovascular and Respiratory Sciences
Integrated Review Group; Clinical Integrative Cardiovascular and
Hematological Sciences Study Section.
Date: October 19-20, 2023.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites Alexandria Old Town, 1900 Diagonal Road,
Alexandria, VA 22314.
Contact Person: Margaret Chandler, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4126, MSC 7814, Bethesda, MD
20892, (301) 435-1743, [email protected].
Name of Committee: Bioengineering Sciences & Technologies
Integrated Review Group; Biodata Management and Analysis Study
Section.
Date: October 19-20, 2023.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Bethesdan Hotel, 8120 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: E. Bryan Crenshaw, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-7129,
[email protected].
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group; Clinical Translational
Imaging Science Study Section.
Date: October 19-20, 2023.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: North Bethesda Marriott Hotel & Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road
North, Bethesda, MD 20852.
Contact Person: Eleni Apostolos Liapi, MD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20817, (301) 867-5309,
[email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Interdisciplinary Clinical Care in
Specialty Care Settings Study Section.
Date: October 19-20, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Bethesdan Hotel, 8120 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Abu Saleh Mohammad Abdullah, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827-4043,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 21, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2023-20980 Filed 9-26-23; 8:45 am]
BILLING CODE 4140-01-P
